A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
|ClinicalTrials.gov Identifier: NCT00616798|
Recruitment Status : Completed
First Posted : February 15, 2008
Last Update Posted : June 24, 2014
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||February 2010|
|Actual Study Completion Date :||February 2010|
|Certification/Extension First Submitted :||August 20, 2013|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Umbricht D, Alberati D, Martin-Facklam M, Borroni E, Youssef EA, Ostland M, Wallace TL, Knoflach F, Dorflinger E, Wettstein JG, Bausch A, Garibaldi G, Santarelli L. Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study. JAMA Psychiatry. 2014 Jun;71(6):637-46. doi: 10.1001/jamapsychiatry.2014.163.